Phase 2 Data from "ASTRAEUS" Trial of Mereo BioPharma's Alvelestat in Alpha-1 Antitrypsin Deficiency-associated Lung Disease Presented at the 2023 American Thoracic Society International Conference
Stock Information for Mereo BioPharma Group plc
Loading
Please wait while we load your information from QuoteMedia.